StonvexLoading…
StonvexStonvexStonvexCore line items from KNTK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.76B | $1.48B | $1.26B | $1.21B |
Operating Income | $164.92M | $179.23M | $159.25M | $150.49M |
Net Income | $178.26M | $80.01M | $289.44M | $250.72M |
EPS (Diluted) | $2.63 | $1.02 | $2.52 | $1.47 |
Total Assets | $7.10B | $6.81B | $6.50B | $5.92B |
Total Liabilities | $4.17B | $3.84B | $3.87B | $3.65B |
Cash & Equivalents | $3.95M | $3.61M | $4.51M | $6.39M |
Free Cash Flow OCF − CapEx | $111.65M | $373.80M | $271.62M | $406.85M |
Shares Outstanding | 62.66M | 60.12M | 146.20M | 41.66M |